MASLD: self-healing hydrogel as promising therapeutic approach

Researchers at National Taiwan University have developed an injectable, self-healing hydrogel designed to treat Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). The material mimics the natural liver environment to restore function and reduce lipid accumulation.
Why it matters
This innovation offers a potential breakthrough in regenerative medicine for liver disease, providing a more effective, biomimetic therapeutic platform.
To address this unmet clinical need, Professor Yung-Te Hou of the Department of Biomechatronics Engineering, National Taiwan University, and colleagues have developed a novel injectable self-healing hydrogel engineered to recapitulate the native hepatic microenvironment and restore liver function in MASLD. The findings were published in Advanced Healthcare Materials.
The CPDP self-healing hydrogel, developed by Professor Shan-hui Hsu at National Taiwan University's Institute of Polymer Science and Engineering, is formed through reversible Schiff-base crosslinking between the amine groups of chitosan-phenol (Chi-Ph) and the benzaldehyde groups of difunctionalized polyethylene glycol (DP-PEG). These dynamic bonds can break and reform, allowing the hydrogel to recover its structure after damage and exhibit self-healing properties.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in